Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' NESLAND JM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 147 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Davidson, B; Reich, R; Goldberg, I; Gotlieb, WH; Kopolovic, J; Berner, A; Ben-Baruch, G; Bryne, M; Nesland, JM
      Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma

      CLINICAL CANCER RESEARCH
    2. Davidson, B; Lazarovici, P; Ezersky, A; Nesland, JM; Berner, A; Risberg, B; Trope, CG; Kristensen, GB; Goscinski, M; van de Putte, G; Reich, R
      Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients

      CLINICAL CANCER RESEARCH
    3. Suo, ZH; Yang, HH; Mei, Q; Skovlund, E; Cui, JG; Nesland, JM
      Type 1 protein tyrosine kinases in Chinese breast carcinomas - A clinicopathologic study

      INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
    4. Peng, Q; Soler, AM; Warloe, T; Nesland, JM; Giercksky, KE
      Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate

      JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
    5. Davidson, B; Reich, R; Berner, A; Givant-Horwitz, V; Goldberg, I; Risberg, B; Kristensen, GB; Trope, CG; Bryne, M; Kopolovic, J; Nesland, JM
      Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels

      EUROPEAN JOURNAL OF CANCER
    6. Forus, A; D'Angelo, A; Henriksen, J; Merla, G; Maelandsmo, GM; Florenes, VA; Olivieri, S; Bjerkehagen, B; Meza-Zepeda, LA; Blanco, FD; Muller, C; Sanvito, F; Kononen, J; Nesland, JM; Fodstad, O; Reymond, A; Kallioniemi, OP; Arrigoni, G; Ballabio, A; Myklebost, O; Zollo, M
      Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas - a possible mechanism for altering the nm23-H1 activity

      ONCOGENE
    7. Suo, ZH; Berner, HS; Risberg, B; Karlsson, MG; Nesland, JM
      Estrogen receptor-alpha and C-ERBB-4 expression in breast carcinomas

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    8. Luksiene, Z; Eggen, I; Moan, J; Nesland, JM; Peng, Q
      Evaluation of protoporphyrin IX production, phototoxicity and cell death pathway induced by hexylester of 5-aminolevulinic acid in Reh and HPB-ALL cells

      CANCER LETTERS
    9. Davidson, B; Goldberg, I; Kopolovic, J; Gotlieb, WH; Givant-Horwitz, V; Nesland, JM; Berner, A; Ben-Baruch, G; Bryne, M; Reich, R
      Expression of angiogenesis-related genes in ovarian carcinoma - A clinicopathologic study

      CLINICAL & EXPERIMENTAL METASTASIS
    10. Borgen, E; Naume, B; Nesland, JM; Nowels, KW; Pavlak, N; Ravkin, I; Goldbard, S
      Use of automated microscopy for the detection of disseminated tumor cells in bone marrow samples

      CYTOMETRY
    11. Suo, ZH; Bjaamer, A; Ottestad, L; Nesland, JM
      Expression of EGFR family and steroid hormone receptors in ductal carcinoma in situ of the breast

      ULTRASTRUCTURAL PATHOLOGY
    12. Berner, HS; Nesland, JM
      Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast

      BREAST CANCER RESEARCH AND TREATMENT
    13. Davidson, B; Risberg, B; Goldberg, I; Nesland, JM; Berner, A; Trope, CG; Kristensen, GB; Bryne, M; Reich, R
      Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients isa marker of poor outcome

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    14. Davidson, B; Risberg, B; Berner, A; Nesland, JM; Trope, CG; Kristensen, GB; Bryne, M; Goscinski, M; de Putte, GV; Florenes, VA
      Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications

      GYNECOLOGIC ONCOLOGY
    15. Davidson, B; Nesland, JM; Goldberg, I; Kopolovic, J; Gotlieb, WH; Byrne, M; Ben-Baruch, G; Berner, A; Reich, R
      Caveolin-1 expression in advanced-stage ovarian carcinoma - A clinicopathologic study

      GYNECOLOGIC ONCOLOGY
    16. Thorstensen, L; Qvist, H; Nesland, JM; Giercksky, KE; Lothe, RA
      Identification of two potential suppressor gene regions on chromosome arm 14q that are commonly lost in advanced colorectal carcinomas

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    17. Saeterdal, I; Bjorheim, J; Lislerud, K; Gjertsen, MK; Bukholm, IK; Olsen, OC; Nesland, JM; Eriksen, JA; Moller, M; Lindblom, A; Gaudernack, G
      Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    18. Florenes, VA; Maelandsmo, GM; Faye, R; Nesland, JM; Holm, R
      Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome

      JOURNAL OF PATHOLOGY
    19. Bukholm, IRK; Bukholm, G; Nesland, JM
      Coexpression of cyclin A and beta-catenin and survival in breast cancer patients

      INTERNATIONAL JOURNAL OF CANCER
    20. Bukholm, IRK; Bukholm, G; Nesland, JM
      Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas

      INTERNATIONAL JOURNAL OF CANCER
    21. Peng, Q; Warloe, T; Moan, J; Godal, A; Apricena, F; Giercksky, KE; Nesland, JM
      Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts

      CANCER RESEARCH
    22. Davidson, B; Goldberg, I; Berner, A; Nesland, JM; Givant-Horwitz, V; Byrne, M; Risberg, B; Kristensen, GB; Trope, CG; Kopolovic, J; Reich, R
      Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions

      AJCP. American journal of clinical pathology
    23. Thorstensen, L; Qvist, H; Heim, S; Liefers, GJ; Nesland, JM; Giercksky, KE; Lothe, RA
      Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients

      NEOPLASIA
    24. Anvar, MD; Khiabani, HZ; Nesland, JM; Stranden, E; Kroese, AJ
      Vascular and stromal features in the skin of the lower limb in patients with chronic critical limb ischaemia (CLI) and oedema

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    25. Florenes, VA; Faye, RS; Maelandsmo, GM; Nesland, JM; Holm, R
      Levels of cyclin D1 and D3 in malignant melanoma: Deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma

      CLINICAL CANCER RESEARCH
    26. De Jonge, ETM; Lindeque, BG; Burger, W; Nesland, JM; Holm, R
      Predicting response to neoadjuvant chemotherapy in patients with cervical carcinoma: can we do without any longer?

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    27. Bironaite, D; Nesland, JM; Dalen, H; Risberg, B; Byrne, M
      N-glycans influence the in vitro adhesive and invasive behaviour of three metastatic cell lines

      TUMOR BIOLOGY
    28. Berner, HS; Davidson, B; Berner, A; Risberg, B; Nesland, JM
      Differential expression of CD44s and CD44v3-10 in adenocarcinoma cells andreactive mesothelial cells in effusions

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    29. Bukholm, IK; Nesland, JM
      Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    30. Baekelandt, M; Holm, R; Nesland, JM; Trope, CG; Kristensen, GB
      Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    31. Berner, HS; Davidson, B; Berner, A; Risberg, B; Kristensen, GB; Trope, CG; Van de Putte, G; Nesland, JM
      Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma - diagnostic and prognostic implications

      CLINICAL & EXPERIMENTAL METASTASIS
    32. Baekelandt, MM; Holm, R; Nesland, JM; Trope, CG; Kristensen, GB
      P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer

      ANTICANCER RESEARCH
    33. Suo, ZH; Nesland, JM
      Phyllodes tumor of the breast: EGFR family expression and relation to clinicopathological features

      ULTRASTRUCTURAL PATHOLOGY
    34. Davidson, B; Gotlieb, WH; Ben-Baruch, G; Nesland, JM; Bryne, M; Goldberg, I; Kopolovic, J; Berner, A
      E-cadherin complex protein expression and survival in ovarian carcinoma

      GYNECOLOGIC ONCOLOGY
    35. Davidson, B; Gotlieb, WH; Ben-Baruch, G; Kopolovic, J; Goldberg, I; Nesland, JM; Berner, A; Bjamer, A; Bryne, M
      Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases - A clinicopathologic study

      GYNECOLOGIC ONCOLOGY
    36. Davidson, B; Berner, A; Nesland, JM; Risberg, B; Kristensen, GB; Trope, CG; Bryne, M
      Carbohydrate antigen expression in primary tumors, metastatic lesions, andserous effusions from patients diagnosed with epithelial ovarian carcinoma: Evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions

      HUMAN PATHOLOGY
    37. Davidson, B; Berner, A; Nesland, JM; Risberg, B; Berner, HS; Trope, CG; Kristensen, GB; Bryne, M; Florenes, VA
      E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions

      JOURNAL OF PATHOLOGY
    38. Bukholm, IK; Nesland, JM; Borresen-Dale, AL
      Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients

      JOURNAL OF PATHOLOGY
    39. Risberg, B; Davidson, B; Dong, HP; Nesland, JM; Berner, A
      Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings

      JOURNAL OF CLINICAL PATHOLOGY
    40. Reed, W; Hannisdal, E; Boehler, PJ; Gundersen, S; Host, H; Nesland, JM
      The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma - A multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years

      CANCER
    41. Kvalheim, G; Pharo, A; Holte, H; Lenschow, E; Wang, MY; Erikstein, B; Kvaloy, S; Nesland, JM; Smeland, E
      Stem cell isolation with immunomagnetic beads and tumor cell contamination

      HEMATOPOIETIC STEM CELL TRANSPLANTION
    42. Borgen, E; Naume, B; Nesland, JM; Kvalheim, G; Beiske, K; Fodstad, O; Diel, I; Solomayer, EF; Theocharous, P; Coombes, RC; Smith, BM; Wunder, E; Marolleau, JP; Garcia, J; Pantel, K
      Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

      CYTOTHERAPY
    43. Baekelandt, M; Holm, R; Trope, CG; Nesland, JM; Kristensen, GB
      Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: An immunohistochemical study

      CLINICAL CANCER RESEARCH
    44. de Jonge, ETM; Viljoen, E; Lindeque, BG; Amant, F; Nesland, JM; Holm, R
      The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    45. Raabe, NK; Sauer, T; Erichsen, A; Nesland, JM; Fossaa, SD
      Breast cancer in the contralateral breast: Incidence and histopathology after unilateral radical treatment of the first breast cancer

      ONCOLOGY REPORTS
    46. Kristensen, VN; Andersen, TI; Erikstein, B; Geitvik, G; Skovlund, E; Nesland, JM; Borresen-Dale, AL
      Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients (vol 8, pg 441, 1998)

      PHARMACOGENETICS
    47. Bjerkehagen, B; Dietrich, C; Reed, V; Micci, F; Saeter, G; Berner, A; Nesland, JM; Heim, S
      Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and identification of a new cytogenetic subgroup characterized by t(9;17) (q22;q11)

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    48. Reed, W; Florenes, VA; Holm, R; Hannisdal, E; Nesland, JM
      Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    49. Baekelandt, M; Holm, R; Trope, CG; Nesland, JM; Kristensen, GB
      The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer

      ANNALS OF ONCOLOGY
    50. Baekelandt, M; Kristensen, GB; Nesland, JM; Trope, CG; Holm, R
      Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 inadvanced ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    51. Hennig, EM; Di Lonardo, A; Venuti, A; Holm, R; Marcante, ML; Nesland, JM
      HPV 16 in multiple neoplastic lesions in women with CINIII

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    52. Hennig, EM; Nesland, JM; Di Lonardo, A; Venuti, A
      Multiple primary cancers and HPV infection: Are they related?

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    53. Hennig, EM; Kvinnsland, S; Holm, R; Nesland, JM
      Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas

      ACTA ONCOLOGICA
    54. Hennig, EM; Suo, ZH; Karlsen, F; Holm, R; Thoresen, S; Nesland, JM
      HPV positive bronchopulmonary carcinomas in women with previous high-gradecervical intraepithelial neoplasia (CIN III)

      ACTA ONCOLOGICA
    55. Davidson, B; Goldberg, I; Gotlieb, WH; Kopolovic, J; Ben-Baruch, G; Nesland, JM; Berner, A; Bryne, M; Reich, R
      High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma

      CLINICAL & EXPERIMENTAL METASTASIS
    56. Baekelandt, M; Kristensen, GB; Trope, CG; Nesland, JM; Holm, R
      Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer

      ANTICANCER RESEARCH
    57. Kvalheim, G; Naume, B; Nesland, JM
      Minimal residual disease in breast cancer

      CANCER AND METASTASIS REVIEWS
    58. Hennig, EM; Suo, ZH; Thoresen, S; Holm, R; Kvinnsland, S; Nesland, JM
      Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III).

      BREAST CANCER RESEARCH AND TREATMENT
    59. Van Slooten, HJ; Van de Vijver, MJ; Borresen, AL; Eyfjord, JE; Valgardsdottir, R; Scherneck, S; Nesland, JM; Devilee, P; Cornelisse, CJ; Van Dierendonck, JH
      Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma

      JOURNAL OF PATHOLOGY
    60. Skomedal, H; Kristensen, GB; Nesland, JM; Borresen-Dale, AL; Trope, C; Holm, R
      TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, cdk4, RB, MDM2, and EGFR in cancers of the uterine corpus

      JOURNAL OF PATHOLOGY
    61. Scheistroen, M; Trope, C; Pettersen, EO; Nesland, JM
      p53 protein expression in squamous cell carcinoma of the vulva

      CANCER
    62. Noodt, BB; Berg, K; Stokke, T; Peng, Q; Nesland, JM
      Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light

      BRITISH JOURNAL OF CANCER
    63. KRISTENSEN VN; ANDERSEN TI; ERIKSTEIN B; GEITVIK G; SKOVLUND E; NESLAND JM; BORRESENDALE AL
      SINGLE TUBE MULTIPLEX POLYMERASE-CHAIN-REACTION GENOTYPE ANALYSIS OF GSTM1, GSTT1 AND GSTP1 - RELATION OF GENOTYPES TO TP53 TUMOR STATUS AND CLINICOPATHOLOGICAL VARIABLES IN BREAST-CANCER PATIENTS

      Pharmacogenetics
    64. VANSLOOTEN HJ; VANVIJVER MJ; BORRESEN AL; EYFJORD E; VALGARODOTTIR R; SCHERNECK S; NESLAND JM; DEVILEE P; CORNELISSE CJ; VANDIERENDONCK JH
      MUTATIONS IN THE P53 GENE, BOTH WITHIN AND OUTSIDE THE ZINC-BINDING DOMAINS, ARE ASSOCIATED WITH INCREASED APOPTOSIS AND MITOSIS IN INVASIVE BREAST CARCINOMAS

      European journal of cancer
    65. BUKHOLM IK; BERNER JM; NESLAND JM; BORRESENDALE AL
      EXPRESSION OF CYCLIN DS IN RELATION TO P53 STATUS IN HUMAN BREAST CARCINOMAS

      Virchows Archiv
    66. LOPES JM; HANNISDAL E; BJERKEHAGEN B; BRULAND OS; DANIELSEN HE; PETTERSEN EO; SOBRINHOSIMCES M; NESLAND JM
      SYNOVIAL SARCOMA - EVALUATION OF PROGNOSIS WITH EMPHASIS ON THE STUDYOF DNA-PLOIDY AND PROLIFERATION (PCNA AND KI-67) MARKERS

      Analytical cellular pathology
    67. Suo, Z; Emilsen, E; Tveit, KM; Nesland, JM
      Type 1 protein tyrosine kinases in benign and malignant breast lesions

      HISTOPATHOLOGY
    68. Bryne, M; Boysen, M; Alfsen, CG; Abeler, VM; Sudbo, J; Nesland, JM; Kristensen, GB; Piffko, J; Bankfalvi, A
      The invasive front of carcinomas. The most important area for tumour prognosis?

      ANTICANCER RESEARCH
    69. NORDAL RR; KRISTENSEN GB; STENWIG AE; TROPE CG; NESLAND JM
      IMMUNOHISTOCHEMICAL ANALYSIS OF P53 PROTEIN IN UTERINE SARCOMAS

      Gynecologic oncology (Print)
    70. BORGEN E; BEISKE K; TRACHSEL S; NESLAND JM; KVALHEIM G; HERSTAD TK; SCHLICHTING E; QVIST H; NAUME B
      IMMUNOCYTOCHEMICAL DETECTION OF ISOLATED EPITHELIAL-CELLS IN BONE-MARROW - NONSPECIFIC STAINING AND CONTRIBUTION BY PLASMA-CELLS DIRECTLY REACTIVE TO ALKALINE-PHOSPHATASE

      Journal of pathology
    71. BUKHOLM IK; NESLAND JM; KARESEN R; JACOBSEN U; BORRESENDALE AL
      E-CADHERIN AND ALPHA-CATENIN, BETA-CATENIN, AND GAMMA-CATENIN PROTEINEXPRESSION IN RELATION TO METASTASIS IN HUMAN BREAST-CARCINOMA

      Journal of pathology
    72. NAUME B; BORGEN E; NESLAND JM; BEISKE K; GILEN E; RENOLEN A; RAVNAS G; QVIST H; KARESEN R; KVALHEIM G
      INCREASED SENSITIVITY FOR DETECTION OF MICROMETASTASES IN BONE-MARROWPERIPHERAL-BLOOD STEM-CELL PRODUCTS FROM BREAST-CANCER PATIENTS BY NEGATIVE IMMUNOMAGNETIC SEPARATION/

      International journal of cancer
    73. NOODT BB; RODAL GH; WAINWRIGHT M; PENG Q; HOROBIN R; NESLAND JM; BERG K
      APOPTOSIS INDUCTION BY DIFFERENT PATHWAYS WITH METHYLENE-BLUE DERIVATIVE AND LIGHT FROM MITOCHONDRIAL SITES IN V79 CELLS

      International journal of cancer
    74. MOAN J; PENG Q; SORENSEN R; IANI V; NESLAND JM
      THE BIOPHYSICAL FOUNDATIONS OF PHOTODYNAMIC THERAPY

      Endoscopy (Stuttgart)
    75. FLORENES VA; MAELANDSMO GM; KERBEL RS; SLINGERLAND JM; NESLAND JM; HOLM R
      PROTEIN EXPRESSION OF THE CELL-CYCLE INHIBITOR P27(KIP1) IN MALIGNANT-MELANOMA - INVERSE CORRELATION WITH DISEASE-FREE SURVIVAL

      The American journal of pathology
    76. REE AH; FLORENES VA; BERG JP; MAELANDSMO GM; NESLAND JM; FODSTAD O
      HIGH-LEVELS OF MESSENGER-RNAS FOR TISSUE INHIBITORS OF METALLOPROTEINASES (TIMP-1 AND TIMP-2) IN PRIMARY BREAST CARCINOMAS ARE ASSOCIATED WITH DEVELOPMENT OF DISTANT METASTASES

      Clinical cancer research
    77. GIERCKSKY HE; THORSTENSEN L; QVIST H; NESLAND JM; LOTHE RA
      COMPARISON OF GENETIC CHANGES IN FROZEN BIOPSIES AND MICRODISSECTED ARCHIVAL MATERIAL FROM THE SAME COLORECTAL LIVER METASTASES

      Diagnostic molecular pathology
    78. LAAKE K; ODEGARD A; ANDERSEN TI; BUKHOLM IK; KARESEN R; NESLAND JM; OTTESTAD L; SHILOH Y; BORRESENDALE AL
      LOSS OF HETEROZYGOSITY AT 11Q23.1 IN BREAST CARCINOMAS - INDICATION FOR INVOLVEMENT OF A GENE DISTAL AND CLOSE TO ATM

      Genes, chromosomes & cancer
    79. BUKHOLM IK; NESLAND JM; KARESEN R; JACOBSEN U; BORRESENDALE AL
      EXPRESSION OF E-CADHERIN AND ITS RELATION TO THE P53 PROTEIN STATUS IN HUMAN BREAST CARCINOMAS

      Virchows Archiv
    80. FONSECA E; NESLAND JM; HOIE J; SOBRINHOSIMOES M
      PATTERN OF EXPRESSION OF INTERMEDIATE CYTOKERATIN FILAMENTS IN THE THYROID-GLAND - AN IMMUNOHISTOCHEMICAL STUDY OF SIMPLE AND STRATIFIED EPITHELIAL-TYPE CYTOKERATINS

      Virchows Archiv
    81. NEDELCHEVA V; ANDERSEN TI; LINDBLOM A; KRISTENSEN T; NESLAND JM; OLSEN A; BORRESENDALE AL
      POLYMORPHISMS IN THE CYP19 (AROMATASE) GENE WITH PUTATIVE ROLE IN THEREGULATION OF GENE-EXPRESSION

      The FASEB journal
    82. LOPES JM; BRULAND OS; BJERKEHAGEN B; SILVA MC; HOLM R; PETTERSEN EO; SOLHEIM OP; SOBRINHOSIMOES M; NESLAND JM
      SYNOVIAL SARCOMA - IMMUNOHISTOCHEMICAL EXPRESSION OF P-GLYCOPROTEIN AND GLUTATHIONE-S-TRANSFERASE-PI AND CLINICAL DRUG-RESISTANCE

      Pathology research and practice
    83. FONSECA E; NESLAND JM; SOBRINHOSIMOES M
      EXPRESSION OF STRATIFIED EPITHELIAL-TYPE CYTOKERATINS IN HYALINIZING TRABECULAR ADENOMAS SUPPORTS THEIR RELATIONSHIP WITH PAPILLARY CARCINOMAS OF THE THYROID

      Histopathology
    84. HOLM R; FLORENES VA; ERIKSTEIN B; NESLAND JM
      EXPRESSION OF STROMELYSIN-3 IN MEDULLARY CARCINOMA OF THE BREAST

      Anticancer research
    85. NORDAL RR; KRISTENSEN GB; STENWIG AE; NESLAND JM; PETTERSEN EO; TROPE CG
      AN EVALUATION OF PROGNOSTIC FACTORS IN UTERINE CARCINOSARCOMA

      Gynecologic oncology
    86. SCHEISTROEN M; TROPE C; KAERN J; PETTERSEN EO; ALFSEN GC; NESLAND JM
      DNA-PLOIDY AND EXPRESSION OF P53 AND C-ERBB-2 IN EXTRAMAMMARY PAGETS-DISEASE OF THE VULVA

      Gynecologic oncology
    87. PENG Q; BERG K; MOAN J; KONGSHAUG M; NESLAND JM
      5-AMINOLEVULINIC ACID-BASED PHOTODYNAMIC THERAPY - PRINCIPLES AND EXPERIMENTAL RESEARCH

      Photochemistry and photobiology
    88. KAREEM BN; KARLSEN F; HOLM R; HENNIG EM; SUO ZH; EMILSEN E; HELLESYLT E; NESLAND JM
      A NOVEL GRID POLYMERASE CHAIN-REACTION (G-PCR) APPROACH AT ULTRASTRUCTURAL LEVEL TO DETECT TARGET DNA IN CELL-CULTURES AND TISSUES

      Journal of pathology
    89. BUKHOLM IK; NESLAND JM; KARESEN R; JACOBSEN U; BORRESEN AL
      RELATIONSHIP BETWEEN ABNORMAL P53 PROTEIN AND FAILURE TO EXPRESS P21 PROTEIN IN HUMAN BREAST CARCINOMAS

      Journal of pathology
    90. BUKHOLM IK; NESLAND JM; KARESEN R; JACOBSEN U; BORRESENDALE AL
      INTERACTION BETWEEN BCL-2 AND P21 (WAF1 CIP1) IN BREAST CARCINOMAS WITH WILD-TYPE P53/

      International journal of cancer
    91. HELLAND A; BORRESENDALE AL; PELTOMAKI P; HEKTOEN M; KRISTENSEN GB; NESLAND JM; DELACHAPELLE A; LOTHE RA
      MICROSATELLITE INSTABILITY IN CERVICAL AND ENDOMETRIAL CARCINOMAS

      International journal of cancer
    92. PENG Q; WARLOE T; BERG K; MOAN J; KONGSHAUG M; GIERCKSKY KE; NESLAND JM
      5-AMINOLEVULINIC ACID-BASED PHOTODYNAMIC THERAPY - CLINICAL RESEARCH AND FUTURE CHALLENGES

      Cancer
    93. PENG Q; MOAN J; WARLOE T; VLADIMIR I; STEEN HB; BJORSETH A; NESLAND JM
      BUILDUP OF ESTERIFIED AMINOLEVULINIC-ACID-DERIVATIVE-INDUCED PORPHYRIN FLUORESCENCE IN NORMAL MOUSE SKIN

      Journal of photochemistry and photobiology.B, Biology
    94. PENG Q; MOAN J; NESLAND JM
      CORRELATION OF SUBCELLULAR AND INTRATUMORAL PHOTOSENSITIZER LOCALIZATION WITH ULTRASTRUCTURAL FEATURES AFTER PHOTODYNAMIC THERAPY

      Ultrastructural pathology
    95. CHITEMERERE M; ANDERSEN TI; HOLM R; KARLSEN F; BORRESEN AL; NESLAND JM
      TP53 ALTERATIONS IN ATYPICAL DUCTAL HYPERPLASIA AND DUCTAL CARCINOMA IN-SITU OF THE BREAST

      Breast cancer research and treatment
    96. LUNDBLAD R; NESLAND JM; GIERCKSKY KE
      GRANULOCYTE-COLONY-STIMULATING FACTOR IMPROVES SURVIVAL RATE AND REDUCES CONCENTRATIONS OF BACTERIA, ENDOTOXIN, TUMOR-NECROSIS-FACTOR, AND ENDOTHELIN-1 IN FULMINANT INTRAABDOMINAL SEPSIS IN RATS

      Critical care medicine
    97. THORSTENSEN L; QVIST H; NESLAND JM; GIERCKSKY KE; LOTHE RA
      ALLELOTYPE PROFILES OF LOCAL RECURRENCES AND DISTANT METASTASES FROM COLORECTAL-CANCER PATIENTS

      International journal of cancer
    98. NOODT BB; BERG K; STOKKE T; PENG Q; NESLAND JM
      APOPTOSIS AND NECROSIS INDUCED WITH LIGHT AND 5-AMINOLEVULINIC ACID-DERIVED PROTOPORPHYRIN-IX

      British Journal of Cancer
    99. DUNSAED CB; DORNISH JM; AASTVEIT TE; NESLAND JM; PETTERSEN EO
      GROWTH-INHIBITION OF HUMAN TUMOR XENOGRAFTS IN NUDE-MICE BY TREATMENTWITH THE ANTITUMOR AGENT 4,6-BENZYLIDENE-D(1)-D-GLUCOSE (P-1013)

      Anti-cancer drugs
    100. HOLM R; HOIE J; KAALHUS O; NESLAND JM
      IMMUNOHISTOCHEMICAL DETECTION OF NM23 NDP KINASE AND CATHEPSIN-D IN MEDULLARY CARCINOMAS OF THE THYROID-GLAND/

      Virchows Archiv


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 22:18:16